drugset / Trial / NCT02940535

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

NCT02940535

Unknown 200 enrolled Navy General Hospital, Beijing
RandomizedParallel-groupOpen-labelTreatment

Summary

The management of the poor responder patients is very difficult. Currently, there is no any standard treatment for poor responder patients. The study is designed to test a modified GnRHa protocol for poor ovarian response, low dose GnRHa early luteal phase down regulation, compare with GnRHa ultra-short protocol. This is a randomized controlled trial.

Timeline

Start
2016-12
Primary completion
2019-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 0.1 mg
Subject Triptorelin Other / unclassified 0.375 mg
Background human chorionic gonadotropin Protein / enzyme biologic